Research article Special Issues

Identification of circulating miRNAs as novel prognostic biomarkers for bladder cancer

  • Received: 20 May 2019 Accepted: 18 August 2019 Published: 05 November 2019
  • MicroRNAs (miRNAs) are a type of ncRNAs with 18-25 nucleotides in length and reported to play crucial roles in human cancers. Bladder cancer is one of the most common causes of cancer-related death. The discovery of new early biomarkers for BC may improve the patients' response to the treatment thus obtaining higher outcomes. The present study identified 7 miRNAs were up-regulated in bladder serum cancer samples compared to normal samples, including hsa-miR-185-5p, hsa-miR-663a, hsa-miR-30c-5p, hsa-miR-3648, hsa-miR-1270, hsa-miR-200c-3p, and hsa-miR-29c-5p. The dysregulation of these miRNAs were correlated to advanced stage and overall survival time in bladder cancer patients. Moreover, we identified a predictive model to predict the prognosis of bladder cancer. Kaplan-Meier survival curve analyses showed that bladder cancer patients with high-risk scores had significantly worse overall survival time than bladder patients with lower risk scores. Furthermore, we constructed a miRNA-mRNA regulating network. Bioinformatics analysis showed these miRNAs were involved in regulating sarcomere organization, positive regulation of multicellular organism growth, phosphorylation, phosphatidylinositol-mediated signaling, and peroxisome proliferator activated receptor signaling pathway. We thought this study could provide novel noninvasive early biomarkers for bladder cancer.

    Citation: Guobing Lin, Cunming Zhang, Xuanyu Chen, Junwei Wang, Song Chen, Siyuan Tang, Tianqiang Yu. Identification of circulating miRNAs as novel prognostic biomarkers for bladder cancer[J]. Mathematical Biosciences and Engineering, 2020, 17(1): 834-844. doi: 10.3934/mbe.2020044

    Related Papers:

  • MicroRNAs (miRNAs) are a type of ncRNAs with 18-25 nucleotides in length and reported to play crucial roles in human cancers. Bladder cancer is one of the most common causes of cancer-related death. The discovery of new early biomarkers for BC may improve the patients' response to the treatment thus obtaining higher outcomes. The present study identified 7 miRNAs were up-regulated in bladder serum cancer samples compared to normal samples, including hsa-miR-185-5p, hsa-miR-663a, hsa-miR-30c-5p, hsa-miR-3648, hsa-miR-1270, hsa-miR-200c-3p, and hsa-miR-29c-5p. The dysregulation of these miRNAs were correlated to advanced stage and overall survival time in bladder cancer patients. Moreover, we identified a predictive model to predict the prognosis of bladder cancer. Kaplan-Meier survival curve analyses showed that bladder cancer patients with high-risk scores had significantly worse overall survival time than bladder patients with lower risk scores. Furthermore, we constructed a miRNA-mRNA regulating network. Bioinformatics analysis showed these miRNAs were involved in regulating sarcomere organization, positive regulation of multicellular organism growth, phosphorylation, phosphatidylinositol-mediated signaling, and peroxisome proliferator activated receptor signaling pathway. We thought this study could provide novel noninvasive early biomarkers for bladder cancer.


    加载中


    [1] A. Q. Gomes, S. Nolasco and H. Soares, Non-coding RNAs: Multi-tasking molecules in the cell, Int. J. Mol. Sci., 14 (2013), 16010-16039.
    [2] N. Asano, J. Matsuzaki, M. Ichikawa, et al., A serum microRNA classifier for the diagnosis of sarcomas of various histological subtypes, Nat. Commun., 10 (2019), 1299.
    [3] L. Falzone, S. Candido, R. Salemi, et al., Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer, Oncotarget, 7 (2016), 72758-72766.
    [4] L. Falzone, G. Lupo, G. R. M. L. Rosa, et al., Identification of Novel MicroRNAs and Their Diagnostic and Prognostic Significance in Oral Cancer, Cancers, 11 (2019), 610.
    [5] P. Anand, A. B. Kunnumakara, C. Sundaram, et al., Cancer is a Preventable Disease that Requires Major Lifestyle Changes, Pharm. Res., 25 (2008), 2097-2116.
    [6] T. Inamoto, H. Uehara, Y. Akao, et al., A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder, Dis. Markers, 2018 (2018), 5468672.
    [7] Y. He, J. Lin, D. Kong, et al., Current State of Circulating MicroRNAs as Cancer Biomarkers, Clin. Chem., 61 (2015), 1138-1155.
    [8] X. Jiang, L. Du, W. Duan, et al., Serum microRNA expression signatures as novel noninvasive biomarkers for prediction and prognosis of muscle-invasive bladder cancer, Oncotarget, 7 (2016), 36733-36742.
    [9] W. Usuba, F. Urabe, Y. Yamamoto, et al., Circulating miRNA panels for specific and early detection in bladder cancer, Cancer Sci., 110 (2019), 408-419.
    [10] D. W. Huang, B. T. Sherman and R. A. Lempicki, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources, Nat. Protoc., 4 (2009), 44-57.
    [11] Z. Wang, M. A. Jensen and J. C. Zenklusen, A Practical Guide to The Cancer Genome Atlas (TCGA), in Statistical Genomics, Humana Press, New York, (2016), 111-141.
    [12] N. Wong, Y. Chen, S. Chen, et al., OncomiR: An online resource for exploring pan-cancer microRNA dysregulation, Bioinformatics, 34 (2018), 713-715.
    [13] C. Sticht, C. D. La Torre, A. Parveen, et al., miRWalk: An online resource for prediction of microRNA binding sites, Plos One, 13 (2018), e0206239.
    [14] N. Wong and X. Wang, miRDB: An online resource for microRNA target prediction and functional annotations, Nucleic Acids Res., 43 (2015), D146-D152.
    [15] J. Yang, J. Li, P. Shao, et al., starBase: A database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data, Nucleic Acids Res., 39 (2011), D202-D209.
    [16] P. Shannon, A. Markiel, O. Ozier, et al., Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks, Genome Res., 13 (2003), 2498-2504.
    [17] S. Ostadrahimi, S. Fayaz, M. Parvizhamidi, et al., Downregulation of miR-1266-5P, miR-185-5P and miR-30c-2 in prostatic cancer tissue and cell lines, Oncol. Lett., 15 (2018), 8157-8164.
    [18] F. Qu, X. Cui, Y. Hong, et al., MicroRNA-185 suppresses proliferation, invasion, migration, and tumorigenicity of human prostate cancer cells through targeting androgen receptor, Mol. Cell. Biochem., 377 (2013), 121-130.
    [19] C. Zhang, B. Chen, A. Jiao, et al., miR-663a inhibits tumor growth and invasion by regulating TGF-beta1 in hepatocellular carcinoma, BMC Cancer, 18 (2018), 1179.
    [20] Y. Zhang, X. Xu, M. Zhang, et al., MicroRNA-663a is downregulated in non-small cell lung cancer and inhibits proliferation and invasion by targeting JunD, BMC Cancer, 16 (2016), 315.
    [21] H. Tang, M. Deng, Y. Tang, et al., miR-200b and miR-200c as Prognostic Factors and Mediators of Gastric Cancer Cell Progression, Clin. Cancer Res., 19 (2013), 5602-5612.
  • Reader Comments
  • © 2020 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(3980) PDF downloads(607) Cited by(14)

Article outline

Figures and Tables

Figures(5)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog